Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results? G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ... Clinical Infectious Diseases 62 (8), 995-1001, 2016 | 164 | 2016 |
False positive Xpert MTB/RIF results in re-tested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes G Theron, R Venter, L Smith, A Esmail, P Randall, V Sood, S Oelfese, ... Journal of Clinical Microbiology, JCM.01696-17, 2018 | 108 | 2018 |
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis G Theron, J Limberis, R Venter, L Smith, E Pietersen, A Esmail, ... Nature medicine 26 (9), 1435-1443, 2020 | 42 | 2020 |
Investigating non-sterilizing cure in TB patients at the end of successful anti-TB therapy CGG Beltran, T Heunis, J Gallant, R Venter, N Du Plessis, AG Loxton, ... Frontiers in cellular and infection microbiology 10, 443, 2020 | 25 | 2020 |
Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response? KV Driessche, PZ Mahlobo, R Venter, J Caldwell, K Jennings, AH Diacon, ... The Lancet Respiratory Medicine 9 (4), 340-342, 2021 | 24 | 2021 |
Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate secondline genotypic drug susceptibility testing and spoligotyping R Venter, B Derendinger, M de Vos, S Pillay, T Dolby, J Simpson, ... Scientific Reports 7 (1), 14854, 2017 | 15 | 2017 |
Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross … R Venter, S Minnies, B Derendinger, H Tshivhula, M De Vos, T Dolby, ... Scientific Reports 10 (1), 2633, 2020 | 7 | 2020 |
Direct genotyping of Mycobacterium tuberculosis from Xpert® MTB/RIF remnants ET Mambuque, E Abascal, R Venter, H Bulo, E Bouza, G Theron, ... Tuberculosis 111, 202-206, 2018 | 6 | 2018 |
Culture filtrate supplementation can be used to improve Mycobacterium tuberculosis culture positivity for spinal tuberculosis diagnosis CGG Beltran, R Venter, TN Mann, JH Davis, BD Kana, G Walzl Frontiers in Cellular and Infection Microbiology 12, 1065893, 2022 | 3 | 2022 |
Frequent suboptimal thermocycler ramp rate usage negatively impacts GenoType MTBDRsl VER 2.0 performance for second-line drug-resistant tuberculosis diagnosis B Derendinger, M de Vos, S Pillay, R Venter, J Metcalfe, Y Ghebrekristos, ... The Journal of Molecular Diagnostics 24 (5), 494-502, 2022 | 3 | 2022 |
Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation YT Ghebrekristos, N Beylis, CM Centner, R Venter, B Derendinger, ... The Lancet Microbe 4 (10), e822-e829, 2023 | 1 | 2023 |
Frequency and clinical profile of false positive Xpert MTB/RIF results in patients previously treated for tuberculosis G Theron, R Venter, L Smith, GL Calligaro, A Esmail, RM Warren, ... A26. DIAGNOSIS AND TREATMENT OF TUBERCULOSIS, A1171-A1171, 2017 | 1 | 2017 |
Subtracting the background: Reducing cell-free DNA's confounding effects on Mycobacterium tuberculosis quantitation and the sputum microbiome CC Naidoo, R Venter, F Codony, G Agusti, N Kitchin, S Naidoo, H Monaco, ... medRxiv, 2024.03. 27.24304911, 2024 | | 2024 |
Something from nothing: Sensitivity and specificity of Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection YT Ghebrekristos, N Beylis, CM Centner, R Venter, B Derendinger, ... medRxiv, 2022.12. 07.22283223, 2022 | | 2022 |
Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?(vol 9, pg 340, 2021) K Vanden Driessche, PZ Mahlobo, R Venter Lancet Respiratory Medicine, E114-E114, 2021 | | 2021 |
Novel approaches for the diagnosis of drug-resistance, treatment response, and infectiousness in patients with tuberculosis (the eDIToR study–Diagnosis Infectiousness and … R Venter Stellenbosch: Stellenbosch University, 2020 | | 2020 |
Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis G Theron, L Smith, JD Limberis, R Venter, A Esmail, R McNerney, ... D96. INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS, A7319-A7319, 2017 | | 2017 |
A26 DIAGNOSIS AND TREATMENT OF TUBERCULOSIS: Frequency And Clinical Profile Of False Positive Xpert Mtb/rif Results In Patients Previously Treated For Tuberculosis G Theron, R Venter, L Smith, GL Calligaro, A Esmail, RM Warren, ... American Journal of Respiratory and Critical Care Medicine 195, 2017 | | 2017 |
D96 INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS: Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis G Theron, L Smith, JD Limberis, R Venter, A Esmail, R McNerney, ... American Journal of Respiratory and Critical Care Medicine 195, 2017 | | 2017 |